Company profile for AFT Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Here at AFT Pharmaceuticals, our company vision is simple: to develop innovative products that help people. We do this by seeing opportunities that others may have missed, and by filling gaps in the market with innovative products that can provide positive health outcomes for those who need them. Our success is built on research and development. R&D is more than ‘corporate speak’ for us: it’s at the heart of what we do ...
Here at AFT Pharmaceuticals, our company vision is simple: to develop innovative products that help people. We do this by seeing opportunities that others may have missed, and by filling gaps in the market with innovative products that can provide positive health outcomes for those who need them. Our success is built on research and development. R&D is more than ‘corporate speak’ for us: it’s at the heart of what we do in developing new products or improving existing ones. This has allowed us to successfully grow our business year after year, and crucially, to meet the health needs of people in Australasia and around the globe.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
New Zealand
Address
Address
Level 1 129 Hurstmere Rd Auckland, NZ
Telephone
Telephone
0800 423 823
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/aft-pharmaceuticals-brings-next-generation-liposomal-collagen-and-wellness-range-to-the-us-market-302612533.html

PR NEWSWIRE
12 Nov 2025

https://www.globenewswire.com/news-release/2023/07/20/2708394/0/en/Crossject-signs-new-licensing-agreement-on-ZENEO-Midazolam-epilepsy-rescue-therapy-with-AFT-Pharmaceuticals-for-Australia-New-Zealand.html

GLOBENEWSWIRE
20 Jul 2023

https://www.prnewswire.com/news-releases/hikma-announces-exclusive-agreement-with-aft-pharmaceuticals-for-injectable-non-opioid-pain-medication-combogesic-iv-in-the-us-301279371.html

PRNEWSWIRE
28 Apr 2021

https://www.prnewswire.com/news-releases/hikma-announces-exclusive-agreement-with-aft-pharmaceuticals-for-injectable-non-opioid-pain-medication-combogesic-iv-in-the-us-301279371.html

PRNEWSWIRE
28 Apr 2021

https://www.globenewswire.com/news-release/2019/11/25/1952283/0/en/BioSyent-Signs-Exclusive-Agreement-for-Pain-Management-Products.html

GLOBE NEWSWIRE
26 Nov 2019

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty